Trusted Healthcare
Toward a Normal Heart Rhythm
Rithim Biologics Inc. Financial Conflict of Interest Policy (FCOI)Rithim Biologics® , Inc. (RBI) is focused on development of cardiac gene therapies and delivery instruments to prevent fast heart rates.
Who we are
Improving Quality of Life (QOL) for cardiac arrhythmia patients
RBI is a Delaware C Corporation founded in 2016 by two highly experienced individuals in the cardiac electrophysiology space.
The company is developing surgical delivery tools and gene therapies to prevent fast heart rates originating in the heart’s upper chambers (atria) and/or lower chambers (ventricles).
Contact Us
Fill out the form below and our team will get back to you shortly. We’re here to provide guidance, support, and the best solutions for your needs.
News
Our latest news update
All news
Investors
Join us in revolutionizing cardiac care through innovative gene therapy solutions.